1
|
Xiao J, Wu H, Liang JR, Wu P, Guo C, Wang YW, Wang ZY, Peng Y. Photocatalytic Tandem Radical Cyclization Enables Expeditious Total Synthesis of Epoxyhinokiol Analogues for Anticancer Activity Evaluation. Org Lett 2024; 26:3481-3486. [PMID: 38240748 DOI: 10.1021/acs.orglett.3c03811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2024]
Abstract
A photocatalytic radical cascade with an unusual endo-trig cyclization was developed, which enables the efficient assembly of divergent tricyclic diterpenoid frameworks. The first total synthesis of abietane 10-epi-epoxyhinoliol was thus achieved in six steps by a subsequent reductive coupling of i-PrBr under photoredox/nickel dual catalysis. Inhibitory tests of chiral 10-epi-epoxyhinoliol and its analogues in 4T1 cancer cells demonstrated the critical role of the C12 hydroxyl group, leading to a discovery of the simplified analogue with better activity.
Collapse
Affiliation(s)
- Jian Xiao
- School of Chemistry, Southwest Jiaotong University, Chengdu 610031, P. R. China
| | - Hao Wu
- School of Chemistry, Southwest Jiaotong University, Chengdu 610031, P. R. China
| | - Jia-Rong Liang
- Spin-X Institute, South China University of Technology, Guangzhou 511422, P. R. China
| | - Ping Wu
- School of Chemistry, Southwest Jiaotong University, Chengdu 610031, P. R. China
| | - Chen Guo
- School of Chemistry, Southwest Jiaotong University, Chengdu 610031, P. R. China
| | - Ya-Wen Wang
- School of Chemistry, Southwest Jiaotong University, Chengdu 610031, P. R. China
| | - Zhi-Yi Wang
- Spin-X Institute, South China University of Technology, Guangzhou 511422, P. R. China
| | - Yu Peng
- School of Chemistry, Southwest Jiaotong University, Chengdu 610031, P. R. China
| |
Collapse
|
2
|
Filipe M, Domínguez-Martín EM, Pires TCP, Finimundy TC, Melgar B, Mandim F, Isca VMS, Pereira R, Teixidó-Trujillo S, Capote NA, Nikolić M, Filipović N, Díaz-Lanza AM, Figueiredo AC, Barros L, Rijo P. Biological Activity of 6,7-Dehydroxyroyleanone and Derivatives Obtained from Plectranthus aliciae (Codd) A.J.Paton. ACS OMEGA 2024; 9:18113-18118. [PMID: 38680304 PMCID: PMC11044231 DOI: 10.1021/acsomega.3c10071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Revised: 03/14/2024] [Accepted: 03/27/2024] [Indexed: 05/01/2024]
Abstract
The Plectranthus genus (Lamiaceae) is known to be rich in abietane diterpenes. The bioactive 6,7-dehydroxyroyleanone (DHR, 1) was previously isolated from Plectranthus madagascariensis var. madagascariensis and var. aliciae. This study aimed to explore the occurrence of DHR, 1, in P. aliciae and the potential bioactivities of new semisynthetic derivatives from DHR, 1. Several extraction methods were evaluated, and the hydrodistillation, using a Clevenger apparatus, afforded the highest yield (77.8 mg/g of 1 in the essential oil). Three new acyl derivatives (2-4) were successfully prepared from 1 (yields of 86-95%). Compounds 1-4 showed antioxidant activity, antibacterial effects, potent cytotoxic activity against several cell lines, and enhanced anti-inflammatory activity that surpassed dexamethasone (positive control). These findings encourage further exploration of derivatives 2-4 for potential mechanisms of antitumoral, antioxidant, and anti-inflammatory capabilities, studying both safety and efficacy.
Collapse
Affiliation(s)
- Márcia
S. Filipe
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
- Departamento
de Ciencias Biomédicas (Área de Farmacología,
Nuevos agentes antitumorales, Acción tóxica sobre células
leucémicas), Facultad de Farmacia, Universidad de Alcalá de Henares, 28805 Madrid, España
| | - Eva M. Domínguez-Martín
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
- Departamento
de Ciencias Biomédicas (Área de Farmacología,
Nuevos agentes antitumorales, Acción tóxica sobre células
leucémicas), Facultad de Farmacia, Universidad de Alcalá de Henares, 28805 Madrid, España
| | - Tânia C.
S. P. Pires
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Tiane C. Finimundy
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Bruno Melgar
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Filipa Mandim
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Vera M. S. Isca
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
- Instituto
de Investigação do Medicamento (iMed.ULisboa), Faculdade
de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal
| | - Raquel Pereira
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
| | - Silvia Teixidó-Trujillo
- Centro Atlántico
del Medicamento S.A., Avenida Trinidad 61, 7a Planta, Torre Agustín Arévalo, 38204 La Laguna, Tenerife, Spain
| | - Natalia A. Capote
- Centro Atlántico
del Medicamento S.A., Avenida Trinidad 61, 7a Planta, Torre Agustín Arévalo, 38204 La Laguna, Tenerife, Spain
| | - Milan Nikolić
- Faculty
of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia
| | - Nenad Filipović
- Faculty
of Agriculture, University of Belgrade, Nemanjina 6, 11000 Belgrade, Serbia
| | - Ana M. Díaz-Lanza
- Departamento
de Ciencias Biomédicas (Área de Farmacología,
Nuevos agentes antitumorales, Acción tóxica sobre células
leucémicas), Facultad de Farmacia, Universidad de Alcalá de Henares, 28805 Madrid, España
| | - Ana Cristina Figueiredo
- Centro
de Estudos do Ambiente e do Mar (CESAM Ciências), Faculdade
de Ciências, Universidade de Lisboa
(FCUL), Biotecnologia Vegetal, DBV, C2, Campo Grande, 1749-016 Lisboa, Portugal
| | - Lillian Barros
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Patrícia Rijo
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
- Instituto
de Investigação do Medicamento (iMed.ULisboa), Faculdade
de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal
| |
Collapse
|
3
|
Hashimoto R, Hanaya K, Sugai T, Higashibayashi S. Unified short syntheses of oxygenated tricyclic aromatic diterpenes by radical cyclization with a photoredox catalyst. Commun Chem 2023; 6:169. [PMID: 37604953 PMCID: PMC10442340 DOI: 10.1038/s42004-023-00979-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Accepted: 08/08/2023] [Indexed: 08/23/2023] Open
Abstract
The biomimetic two-phase strategy employing polyene cyclization and subsequent oxidation/substitution is an effective approach for divergent syntheses of [6-6-6]-tricyclic diterpenes. However, this strategy requires lengthy sequences for syntheses of oxygenated tricyclic aromatic abietane/podocarpane diterpenes owing to the many linear oxidation/substitution steps after cyclization. Here, we present a new synthetic route based on a convergent reverse two-phase strategy employing a reverse radical cyclization approach, which enabled the unified short syntheses of four aromatic abietane/podocarpane diterpenes and the divergent short syntheses of other related diterpenes. Oxygenated and substituted precursors for cyclization were convergently prepared through Friedel-Crafts acylation and rhodium-catalyzed site-selective iodination. Radical redox cyclization using an iridium photoredox catalyst involving neophyl rearrangement furnished the thermodynamically favored 6-membered ring preferentially. (±)-5,6-Dehydrosugiol, salvinolone, crossogumerin A, and Δ5-nimbidiol were synthesized in only 8 steps. An oxygenated cyclized intermediate was also useful for divergent derivatization to sugiol, ferruginol, saprorthoquinone, cryptomeriololide, and salvinolone.
Collapse
Affiliation(s)
- Riichi Hashimoto
- Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
| | - Kengo Hanaya
- Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan
| | - Takeshi Sugai
- Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan
| | - Shuhei Higashibayashi
- Faculty of Pharmacy, Keio University, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan.
| |
Collapse
|
4
|
Hu YJ, Lan Q, Su BJ, Chen ZF, Liang D. Structurally diverse abietane-type Diterpenoids from the aerial parts of Gaultheria leucocarpa var. yunnanensis. PHYTOCHEMISTRY 2022; 201:113255. [PMID: 35636565 DOI: 10.1016/j.phytochem.2022.113255] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/25/2022] [Revised: 05/20/2022] [Accepted: 05/22/2022] [Indexed: 06/15/2023]
Abstract
Seven undescribed abietane-type diterpenoids, gauleucins A-G, and 11 known ones were isolated from an EtOH extract of the aerial parts of Gaultheria leucocarpa var. yunnanensis. These isolates could be classified into four subtypes: abietanes, 16-nor-abietanes, 16,18-di-nor-abietanes, and 3,4-seco-16-nor-abietane. Their structures were established by extensive spectroscopic analysis, and the absolute configurations of an undescribed and two known diterpenoids were determined by single-crystal X-ray diffraction data. Four compounds showed moderate inhibitory effects against the LPS-induced production of nitric oxide in BV-2 microglial cells. In an α-glucosidase inhibitory assay, gauleucin E and margoclin displayed inhibitory activities with IC50 values of 319.3 and 327.9 μM, respectively, while the IC50 value of the positive control (acarbose) was 387.8 μM.
Collapse
Affiliation(s)
- Ya-Jie Hu
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China
| | - Qian Lan
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China
| | - Bao-Jun Su
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China
| | - Zhen-Feng Chen
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China
| | - Dong Liang
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin, 541004, People's Republic of China.
| |
Collapse
|
5
|
Domínguez-Martín EM, Magalhães M, Díaz-Lanza AM, Marques MP, Princiotto S, Gómez AM, Efferth T, Cabral C, Rijo P. Phytochemical Study and Antiglioblastoma Activity Assessment of Plectranthus hadiensis (Forssk.) Schweinf. ex Sprenger var. hadiensis Stems. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27123813. [PMID: 35744938 PMCID: PMC9230782 DOI: 10.3390/molecules27123813] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Revised: 06/10/2022] [Accepted: 06/11/2022] [Indexed: 11/22/2022]
Abstract
Glioblastoma (GB) is the most malignant form of primary astrocytoma, accounting for more than 60% of all brain tumors in adults. Nowadays, due to the development of multidrug resistance causing relapses to the current treatments and the development of severe side effects resulting in reduced survival rates, new therapeutic approaches are needed. The genus Plectranthus belongs to the Lamiaceae family and is known to be rich in abietane-type diterpenes, which possess antitumor activity. Specifically, P. hadiensis (Forssk.) Schweinf. ex Sprenger has been documented for the use against brain tumors. Therefore, the aim of this work was to perform the bioguided isolation of compounds from the acetonic extract of P. hadiensis stems and to investigate the in vitro antiglioblastoma activity of the extract and its isolated constituents. After extraction, six fractions were obtained from the acetonic extract of P. hadiensis stems. In a preliminary biological screening, the fractions V and III showed the highest antioxidant and antimicrobial activities. None of the fractions were toxic in the Artemia salina assay. We obtained different abietane-type diterpenes such as 7α-acetoxy-6β-hydroxyroyleanone (Roy) and 6β,7β-dihydroxyroyleanone (DiRoy), which was also in agreement with the HPLC-DAD profile of the extract. Furthermore, the antiproliferative activity was assessed in a glioma tumor cell line panel by the Alamar blue assay. After 48 h treatment, Roy exerted strong antiproliferative/cytotoxic effects against tumor cells with low IC50 values among the different cell lines. Finally, we synthesized a new fluorescence derivative in this study to evaluate the biodistribution of Roy. The uptake of BODIPY-7α-acetoxy-6β-hydroxyroyleanone by GB cells was associated with increased intracellular fluorescence, supporting the antiproliferative effects of Roy. In conclusion, Roy is a promising natural compound that may serve as a lead compound for further derivatization to develop future therapeutic strategies against GB.
Collapse
Affiliation(s)
- Eva María Domínguez-Martín
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.M.D.-M.); (S.P.)
- New Antitumor Compounds—Toxic Action on Leukemia Cells Research Group, Pharmacology Area (Pharmacognosy Laboratory), Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100—Campus Universitario, Alcalá de Henares, 28805 Madrid, Spain;
| | - Mariana Magalhães
- PhD Programme in Experimental Biology and Biomedicine, Institute for Interdisciplinary Research (IIIUC), University of Coimbra, Casa Costa Alemão, 3030-789 Coimbra, Portugal;
- CNC—Center for Neuroscience and Cell Biology, University of Coimbra, 3004-516 Coimbra, Portugal
- Faculty of Medicine, Clinic Academic Center of Coimbra (CACC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, 3000-548 Coimbra, Portugal;
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal
| | - Ana María Díaz-Lanza
- New Antitumor Compounds—Toxic Action on Leukemia Cells Research Group, Pharmacology Area (Pharmacognosy Laboratory), Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100—Campus Universitario, Alcalá de Henares, 28805 Madrid, Spain;
| | - Mário P. Marques
- Faculty of Medicine, Clinic Academic Center of Coimbra (CACC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, 3000-548 Coimbra, Portugal;
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal
| | - Salvatore Princiotto
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.M.D.-M.); (S.P.)
| | - Ana M. Gómez
- Instituto de Química Orgánica, IQOG-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain;
| | - Thomas Efferth
- Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany;
| | - Célia Cabral
- Faculty of Medicine, Clinic Academic Center of Coimbra (CACC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, 3000-548 Coimbra, Portugal;
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal
- Centre for Functional Ecology, Department of Life Sciences, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal
- Correspondence: (C.C.); (P.R.)
| | - Patricia Rijo
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.M.D.-M.); (S.P.)
- Instituto de Investigação do Medicamento (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, Portugal
- Correspondence: (C.C.); (P.R.)
| |
Collapse
|
6
|
Abietane Diterpenes of the Genus Plectranthus sensu lato. Molecules 2021; 27:molecules27010166. [PMID: 35011401 PMCID: PMC8746610 DOI: 10.3390/molecules27010166] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2021] [Revised: 12/13/2021] [Accepted: 12/16/2021] [Indexed: 12/20/2022] Open
Abstract
Plectranthus (Lamiaceae), which—according to the latest systematic revision—includes three separate genera (Coleus, Plectranthus sensu stricto, and Equilabium), is a genus widely used in traditional medicine—mainly in the treatment of various ailments of the digestive tract, respiratory tract, and skin. Many species of Plectranthus s.l. have been shown to produce phenolic compounds and terpenes. Diterpenes, especially those of the abietane class, are the most studied group of secondary metabolites found in Plectranthus s.l., which is characterized by a significant structural diversity arising from the oxygenation and further rearrangement of the basic tricyclic abietane skeleton to a complete aromatization of the ring system. This review summarizes the known information on abietane diterpenes, showing their structures, sources, and biosynthesis. A classification of these compounds into nine groups, according to the arrangement of their ring C, is used. Royleanones, spirocoleons, and hydroquinones are the largest classes of abietane diterpenes, covering more than 70% of all the compounds reviewed.
Collapse
|